SCHEMBL22493573

SCHEMBL22493573

O=C(O)N1[C@@H]2CC[C@H]1C[C@](Cc1ccccc1)(C(=O)O)C2

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.41
OPRM1 P35372 3/20 0.41
OPRL1 P41146 3/20 0.41
KDM4E B2RXH2 1/20 0.39
LMNA P02545 1/20 0.38
ALDH1A1 P00352 2/20 0.37
GLA P06280 1/20 0.37
HPGD P15428 1/20 0.37
HRH3 Q9Y5N1 1/20 0.37
GRIN2B Q13224 1/20 0.36
HSD11B1 P28845 1/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
CYP3A4 P08684 1/20 0.36
GRM6 O15303 1/20 0.36
CHRM2 P08172 1/20 0.36
CHRM3 P20309 1/20 0.36
TSHR P16473 1/20 0.36
DPP4 P27487 1/20 0.36
SMN1; SMN2 Q16637 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22493574 1.00 GRM5 (0.41) GRM5OPRM1OPRL1KDM4ELMNA
SCHEMBL22493575 1.00 GRM5 (0.41) GRM5OPRM1OPRL1KDM4ELMNA
SCHEMBL29214271 0.77 HSD11B1 (0.41) ALDH1A1HPGDGRIN2BHSD11B1MEN1
SCHEMBL23927554 0.74 MAOA (0.40) LMNAHPGDGRIN2BHSD11B1MEN1
Hydrochloric Acid SCHEMBL28556134 0.74 TACR3 (0.41) HSD11B1MEN1KMT2A
SCHEMBL923461 0.73 MAOA (0.48) KDM4ELMNAALDH1A1HSD11B1
SCHEMBL13739350 0.72 GRM5 (0.74) GRM5
SCHEMBL4591914 0.71 CHRM2 (0.45) GRM5KDM4ELMNAALDH1A1MEN1
SCHEMBL29832241 0.71 GRM5 (0.48) GRM5KDM4ELMNAHSD11B1KMT2A
SCHEMBL5195183 0.71 OPRL1 (0.54) GRM5OPRM1OPRL1KDM4ELMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240124453-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2024-04-18 US disclosed
US-11884664-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2024-01-30 US disclosed
US-11634417-B2 Protein tyrosine phosphatase inhibitors ARRAY BIOPHARMA INC. (US) 2023-04-25 US disclosed
US-20200317665-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS ARRAY BIOPHARMA INC. (US) 2020-10-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11884664-B2 Protein tyrosine phosphatase inhibitors PPM1A, PPM1F, PPP5C GRM5 4289/4885OPRM1 4660/4885OPRL1 4047/4885
US-20200317665-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C GRM5 4289/4885OPRM1 4660/4885OPRL1 4047/4885
US-20240124453-A1 PROTEIN TYROSINE PHOSPHATASE INHIBITORS PPM1A, PPM1F, PPP5C GRM5 4289/4885OPRM1 4660/4885OPRL1 4047/4885
US-11634417-B2 Protein tyrosine phosphatase inhibitors PPM1A, PPM1F, PPP5C GRM5 4289/4885OPRM1 4660/4885OPRL1 4047/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.